LENALIDOMIDE ASSOCIATED İMMUNE THROMBOCYTOPENIA: A CASE REPORT
Objective: Autoimmune cytopenia is observed in many hematological malignancies, whereas immune thrombocytopenia is rarely observed in plasma cell dyscrasias, such as multiple myeloma. On the other hand, cytopenias secondary to myelosuppression due to lenalidomide use are frequently observed, whereas...
Saved in:
Main Authors: | İbrahim Halil Acar, Birol Guvenc |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/88621bf8e04e42c5b9e0d9f830cda074 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
by: Ayşegül Ünüvar, et al.
Published: (2021) -
A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION
by: Mine KARADENIZ, et al.
Published: (2021) -
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
by: Elrazi Ali, et al.
Published: (2021) -
IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
by: Hana Qasim
Published: (2021) -
Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
by: Brian Eyden, et al.
Published: (2021)